ODP397 Small-volume, Subcutaneous, 6-month Leuprolide Acetate Effectively Reduces Growth Velocity to Prepubertal Levels in Children with Central Precocious Puberty

INTRODUCTION: Clinical signs of puberty, growth rate, rate of bone maturation, luteinizing hormone concentrations and estimates of change in predicted adult height are the common variables for assessing efficacy of central precocious puberty (CPP) therapies. (1, 2) All clinical and laboratory parame...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Karen O, Atkinson, Stuart N, Boldt-Houle, Deborah M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625417/
http://dx.doi.org/10.1210/jendso/bvac150.1261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625417/
http://dx.doi.org/10.1210/jendso/bvac150.1261

Ejemplares similares